English

RAPTOR PHARMACEUTICALS CORP.

EDGAR

Annual report amendment (10-K/A) · filed 2009-11-05

33 filing records in this dataset, filed from 2004-03-30 to 2009-11-05. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2009-05-31 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-2.81 million USD

2009-05-31 · USD

Exact inputs and evidence

Operating Cash Flow: -6991897 USD Source
Operating Cash Flow: -4185371 USD Source

Cash and cash equivalents: 7.55 million USD 2009-08-31 Source
Exact value

7546912 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-8.05 million USD

2008-09-01 – 2009-08-31

Exact inputs and evidence

Net income: -2458998 USD · 2008-09-01 – 2008-11-30 Source
Net income: -2250838 USD · 2008-12-01 – 2009-02-28 Source
Net income: -2564646 USD · 2009-03-01 – 2009-05-31 Source
Net income: -8053963 USD · 2008-09-01 – 2009-08-31 Source
Net income: -7274480 USD · 2008-09-01 – 2009-05-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2009-11-05.

Financial data available through: 2009-08-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2009-08-31
Operating income: 3 of 11 periods available· newest 2009-08-31
Net income: 7 of 11 periods available· newest 2009-08-31
Operating cash flow: 6 of 11 periods available· newest 2009-08-31
Capital expenditure: 3 of 11 periods available· newest 2005-08-31
Total assets: 5 of 11 periods available· newest 2009-08-31
Total liabilities: 3 of 11 periods available· newest 2009-08-31
Current assets: 5 of 11 periods available· newest 2009-08-31
Current liabilities: 5 of 11 periods available· newest 2009-08-31
Cash and cash equivalents: 5 of 11 periods available· newest 2009-08-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

2007-09-01 – 2008-08-31
Current period

USD 0

2008-09-01 – 2009-08-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2007-09-01 – 2008-08-31
Inspect prior input Prior source
0 USD · 2008-09-01 – 2009-08-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · RAPTOR PHARMACEUTICALS CORP. · 2009-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2008-09-01 to 2009-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2008-09-01 to 2009-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0000950123-09-054268.txt#9454 Input fundies:Revenue: 0 USD (2007-09-01 to 2008-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001362310-08-008533.txt#7614
The citation records this snapshot. The page link may show a newer release later.
Net income
USD 0

Prior period

−USD 8.05 million

2007-09-01 – 2008-08-31
Current period

−USD 8.05 million

2008-09-01 – 2009-08-31

Exact inputs and evidence

-8053963 − -8053963 = 0 USD

-8053963 USD · 2007-09-01 – 2008-08-31
Inspect prior input Prior source
-8053963 USD · 2008-09-01 – 2009-08-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · RAPTOR PHARMACEUTICALS CORP. · 2009-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Year-over-year change in Net income: 0 USD Concept: fundies:NetIncome Period: 2008-09-01 to 2009-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -8053963 USD (2008-09-01 to 2009-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0000950123-09-054268.txt#12408 Input fundies:NetIncome: -8053963 USD (2007-09-01 to 2008-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001362310-08-008533.txt#7783
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2009 2008-09-01 – 2009-08-31

Revenue USD 0
Operating costs Derived USD 8.03 million
Operating income −USD 8.03 million
Tax, interest and other Derived USD 25,327
Net income −USD 8.05 million

Cash

Operating cash flow −USD 6.05 million
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2004 Not shown: operating income or net income is not reported.
2005 Not shown: operating income or net income is not reported.
2007 Not shown: operating income or net income is not reported.
2008 Not shown: operating income or net income is not reported.
2009 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2004 2003-09-01 – 2004-08-31	0	Unavailable	Unavailable	Unavailable	-25552	-26665 Derived	Source 2003-09-01 – 2004-08-31: 0 USD Inspect Revenue Open source 2003-09-01 – 2004-08-31: -25552 USD Inspect Net Income Open source 2003-09-01 – 2004-08-31: -24240 USD Inspect Operating Cash Flow Open source 2003-09-01 – 2004-08-31: 2425 USD Inspect Capital Expenditure Open source
2005 2004-09-01 – 2005-08-31	7130	Unavailable	Unavailable	Unavailable	-238010	-195713 Derived	Source 2004-09-01 – 2005-08-31: 7130 USD Inspect Revenue Open source 2004-09-01 – 2005-08-31: -238010 USD Inspect Net Income Open source 2004-09-01 – 2005-08-31: -194447 USD Inspect Operating Cash Flow Open source 2004-09-01 – 2005-08-31: 1266 USD Inspect Capital Expenditure Open source
2007 2006-09-01 – 2007-08-31	0	3775085 Derived	-3775085	-143009 Derived	-3632076	Unavailable	Source 2006-09-01 – 2007-08-31: 0 USD Inspect Revenue Open source 2006-09-01 – 2007-08-31: -3775085 USD Inspect Operating Income Open source 2006-09-01 – 2007-08-31: -3632076 USD Inspect Net Income Open source 2006-09-01 – 2007-08-31: -1045117 USD Inspect Operating Cash Flow Open source
2008 2007-09-01 – 2008-08-31	0	8028636 Derived	-8028636	25327 Derived	-8053963	Unavailable	Source 2007-09-01 – 2008-08-31: 0 USD Inspect Revenue Open source 2007-09-01 – 2008-08-31: -8028636 USD Inspect Operating Income Open source 2007-09-01 – 2008-08-31: -8053963 USD Inspect Net Income Open source
2009 2008-09-01 – 2009-08-31	0	8028636 Derived	-8028636	25327 Derived	-8053963	Unavailable	Source 2008-09-01 – 2009-08-31: 0 USD Inspect Revenue Open source 2008-09-01 – 2009-08-31: -8028636 USD Inspect Operating Income Open source 2008-09-01 – 2009-08-31: -8053963 USD Inspect Net Income Open source 2008-09-01 – 2009-08-31: -6045368 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2009

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-08-31	Revenue	0	Revenue: 0 Open source
20052005-08-31	Revenue	7130	Revenue: 7130 Open source
20072007-08-31	Revenue	0	Revenue: 0 Open source
20082008-08-31	Revenue	0	Revenue: 0 Open source
20092009-08-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20042004-08-31	Year over year	No prior comparable period	Revenue: 0 Open source
20052005-08-31	Year over year	No prior comparable period	Revenue: 7130 Open source Revenue: 0 Open source
20072007-08-31	Year over year	No prior comparable period	Revenue: 0 Open source
20082008-08-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20092009-08-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Net margin -3,338.1% 2005

Free cash flow margin -2,744.9% 2005

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2004-08-31	Operating margin	Not reported	Revenue: 0 Open source
2005-08-31	Operating margin	Not reported	Revenue: 7130 Open source
20072007-08-31	Operating margin	Not reported	Operating Income: -3775085 Open source Revenue: 0 Open source
20082008-08-31	Operating margin	Not reported	Operating Income: -8028636 Open source Revenue: 0 Open source
20092009-08-31	Operating margin	Not reported	Operating Income: -8028636 Open source Revenue: 0 Open source
20042004-08-31	Net margin	Not reported	Net Income: -25552 Open source Revenue: 0 Open source
20052005-08-31	Net margin	-3,338.1%	Net Income: -238010 Open source Revenue: 7130 Open source
20072007-08-31	Net margin	Not reported	Net Income: -3632076 Open source Revenue: 0 Open source
20082008-08-31	Net margin	Not reported	Net Income: -8053963 Open source Revenue: 0 Open source
20092009-08-31	Net margin	Not reported	Net Income: -8053963 Open source Revenue: 0 Open source
20042004-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -24240 Open source Capital Expenditure: 2425 Open source
20052005-08-31	Free cash flow margin	-2,744.9%	Revenue: 7130 Open source Operating Cash Flow: -194447 Open source Capital Expenditure: 1266 Open source
20072007-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1045117 Open source
20082008-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source
20092009-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -6045368 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -6M 2009

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-08-31	Operating cash flow	-24240	Operating Cash Flow: -24240 Open source
20052005-08-31	Operating cash flow	-194447	Operating Cash Flow: -194447 Open source
20072007-08-31	Operating cash flow	-1045117	Operating Cash Flow: -1045117 Open source
20082008-08-31	Operating cash flow	Not reported	No source recorded
20092009-08-31	Operating cash flow	-6045368	Operating Cash Flow: -6045368 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -195.7K 2005

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-08-31	Free cash flow	-26665	Operating Cash Flow: -24240 Open source Capital Expenditure: 2425 Open source
20052005-08-31	Free cash flow	-195713	Operating Cash Flow: -194447 Open source Capital Expenditure: 1266 Open source
20072007-08-31	Free cash flow	Unavailable	Operating Cash Flow: -1045117 Open source
20082008-08-31	Free cash flow	Unavailable	No source recorded
20092009-08-31	Free cash flow	Unavailable	Operating Cash Flow: -6045368 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

16.4% 2009

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2004-08-31	Liabilities / assets	Not reported	Total Assets: 78391 Open source
2005-08-31	Liabilities / assets	Not reported	Total Assets: 62835 Open source
20072007-08-31	Liabilities / assets	10.1%	Total Liabilities: 332816 Open source Total Assets: 3290925 Open source
20082008-08-31	Liabilities / assets	9.4%	Total Liabilities: 1003280 Open source Total Assets: 10620770 Open source
20092009-08-31	Liabilities / assets	16.4%	Total Liabilities: 1075613 Open source Total Assets: 6578574 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.56× 2009

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20042004-08-31	Current assets / current liabilities	15.9×	Current Assets: 75966 Open source Current Liabilities: 4778 Open source
20052005-08-31	Current assets / current liabilities	0.3×	Current Assets: 47694 Open source Current Liabilities: 156376 Open source
20072007-08-31	Current assets / current liabilities	8.54×	Current Assets: 2824165 Open source Current Liabilities: 330514 Open source
20082008-08-31	Current assets / current liabilities	7.64×	Current Assets: 7662506 Open source Current Liabilities: 1003280 Open source
20092009-08-31	Current assets / current liabilities	3.56×	Current Assets: 3808841 Open source Current Liabilities: 1068937 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2002 2001-09-01 – 2002-08-31	−USD 2,024 Exact value Exact value: -2024 USD 2001-09-01 – 2002-08-31: -2024 USD Inspect Net Income Open source Share or cite Citation for Net Income · RAPTOR PHARMACEUTICALS CORP. · 2002-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Net Income: -2024 USD Concept: fundies:NetIncome Period: 2001-09-01 to 2002-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944/explain?concept=fundies%3ANetIncome&period=2002-08-31&surface=latest&period_type=duration&start=2001-09-01&unit=USD&dimensions= Input fundies:NetIncome: -2024 USD (2001-09-01 to 2002-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001256485-04-000005.txt#725 The citation records this snapshot. The page link may show a newer release later.	−USD 24 Exact value Exact value: -24 USD 2001-09-01 – 2002-08-31: -24 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RAPTOR PHARMACEUTICALS CORP. · 2002-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Operating Cash Flow: -24 USD Concept: fundies:OperatingCashFlow Period: 2001-09-01 to 2002-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944/explain?concept=fundies%3AOperatingCashFlow&period=2002-08-31&surface=latest&period_type=duration&start=2001-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24 USD (2001-09-01 to 2002-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001256485-04-000005.txt#761 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2002-09-01 – 2003-08-31	−USD 3,945 Exact value Exact value: -3945 USD 2002-09-01 – 2003-08-31: -3945 USD Inspect Net Income Open source Share or cite Citation for Net Income · RAPTOR PHARMACEUTICALS CORP. · 2003-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Net Income: -3945 USD Concept: fundies:NetIncome Period: 2002-09-01 to 2003-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944/explain?concept=fundies%3ANetIncome&period=2003-08-31&surface=latest&period_type=duration&start=2002-09-01&unit=USD&dimensions= Input fundies:NetIncome: -3945 USD (2002-09-01 to 2003-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001085037-04-001467.txt#973 The citation records this snapshot. The page link may show a newer release later.	−USD 5,300 Exact value Exact value: -5300 USD 2002-09-01 – 2003-08-31: -5300 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RAPTOR PHARMACEUTICALS CORP. · 2003-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Operating Cash Flow: -5300 USD Concept: fundies:OperatingCashFlow Period: 2002-09-01 to 2003-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944/explain?concept=fundies%3AOperatingCashFlow&period=2003-08-31&surface=latest&period_type=duration&start=2002-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5300 USD (2002-09-01 to 2003-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001085037-04-001467.txt#1043 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2002-09-01 – 2003-08-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RAPTOR PHARMACEUTICALS CORP. · 2003-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2002-09-01 to 2003-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944/explain?concept=fundies%3ACapitalExpenditure&period=2003-08-31&surface=latest&period_type=duration&start=2002-09-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2002-09-01 to 2003-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001085037-04-001467.txt#1065 The citation records this snapshot. The page link may show a newer release later.	−USD 5,300 Calculation and evidence -5300 − 0 USD Exact free cash flow: -5300 USD 2002-09-01 – 2003-08-31: -5300 USD · Inspect Operating Cash Flow · Source 2002-09-01 – 2003-08-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RAPTOR PHARMACEUTICALS CORP. · 2003-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Free cash flow: -5300 USD Concept: free-cash-flow Period: 2002-09-01 to 2003-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5300 USD (2002-09-01 to 2003-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001085037-04-001467.txt#1043 Input fundies:CapitalExpenditure: 0 USD (2002-09-01 to 2003-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001085037-04-001467.txt#1065 The citation records this snapshot. The page link may show a newer release later.
2004 2003-09-01 – 2004-08-31	−USD 25,552 Exact value Exact value: -25552 USD 2003-09-01 – 2004-08-31: -25552 USD Inspect Net Income Open source Share or cite Citation for Net Income · RAPTOR PHARMACEUTICALS CORP. · 2004-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Net Income: -25552 USD Concept: fundies:NetIncome Period: 2003-09-01 to 2004-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944/explain?concept=fundies%3ANetIncome&period=2004-08-31&surface=latest&period_type=duration&start=2003-09-01&unit=USD&dimensions= Input fundies:NetIncome: -25552 USD (2003-09-01 to 2004-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001085037-05-001843.txt#2016 The citation records this snapshot. The page link may show a newer release later.	−USD 24,240 Exact value Exact value: -24240 USD 2003-09-01 – 2004-08-31: -24240 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RAPTOR PHARMACEUTICALS CORP. · 2004-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Operating Cash Flow: -24240 USD Concept: fundies:OperatingCashFlow Period: 2003-09-01 to 2004-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944/explain?concept=fundies%3AOperatingCashFlow&period=2004-08-31&surface=latest&period_type=duration&start=2003-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24240 USD (2003-09-01 to 2004-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001085037-05-001843.txt#2172 The citation records this snapshot. The page link may show a newer release later.	USD 2,425 Exact value Exact value: 2425 USD 2003-09-01 – 2004-08-31: 2425 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RAPTOR PHARMACEUTICALS CORP. · 2004-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Capital Expenditure: 2425 USD Concept: fundies:CapitalExpenditure Period: 2003-09-01 to 2004-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944/explain?concept=fundies%3ACapitalExpenditure&period=2004-08-31&surface=latest&period_type=duration&start=2003-09-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2425 USD (2003-09-01 to 2004-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001085037-05-001843.txt#2196 The citation records this snapshot. The page link may show a newer release later.	−USD 26,665 Calculation and evidence -24240 − 2425 USD Exact free cash flow: -26665 USD 2003-09-01 – 2004-08-31: -24240 USD · Inspect Operating Cash Flow · Source 2003-09-01 – 2004-08-31: 2425 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RAPTOR PHARMACEUTICALS CORP. · 2004-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Free cash flow: -26665 USD Concept: free-cash-flow Period: 2003-09-01 to 2004-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -24240 USD (2003-09-01 to 2004-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001085037-05-001843.txt#2172 Input fundies:CapitalExpenditure: 2425 USD (2003-09-01 to 2004-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001085037-05-001843.txt#2196 The citation records this snapshot. The page link may show a newer release later.
2005 2004-09-01 – 2005-08-31	−USD 238,010 Exact value Exact value: -238010 USD 2004-09-01 – 2005-08-31: -238010 USD Inspect Net Income Open source Share or cite Citation for Net Income · RAPTOR PHARMACEUTICALS CORP. · 2005-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Net Income: -238010 USD Concept: fundies:NetIncome Period: 2004-09-01 to 2005-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944/explain?concept=fundies%3ANetIncome&period=2005-08-31&surface=latest&period_type=duration&start=2004-09-01&unit=USD&dimensions= Input fundies:NetIncome: -238010 USD (2004-09-01 to 2005-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001085037-05-001843.txt#2016 The citation records this snapshot. The page link may show a newer release later.	−USD 194,447 Exact value Exact value: -194447 USD 2004-09-01 – 2005-08-31: -194447 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RAPTOR PHARMACEUTICALS CORP. · 2005-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Operating Cash Flow: -194447 USD Concept: fundies:OperatingCashFlow Period: 2004-09-01 to 2005-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944/explain?concept=fundies%3AOperatingCashFlow&period=2005-08-31&surface=latest&period_type=duration&start=2004-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -194447 USD (2004-09-01 to 2005-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001085037-05-001843.txt#2172 The citation records this snapshot. The page link may show a newer release later.	USD 1,266 Exact value Exact value: 1266 USD 2004-09-01 – 2005-08-31: 1266 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RAPTOR PHARMACEUTICALS CORP. · 2005-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Capital Expenditure: 1266 USD Concept: fundies:CapitalExpenditure Period: 2004-09-01 to 2005-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944/explain?concept=fundies%3ACapitalExpenditure&period=2005-08-31&surface=latest&period_type=duration&start=2004-09-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1266 USD (2004-09-01 to 2005-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001085037-05-001843.txt#2196 The citation records this snapshot. The page link may show a newer release later.	−USD 195,713 Calculation and evidence -194447 − 1266 USD Exact free cash flow: -195713 USD 2004-09-01 – 2005-08-31: -194447 USD · Inspect Operating Cash Flow · Source 2004-09-01 – 2005-08-31: 1266 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RAPTOR PHARMACEUTICALS CORP. · 2005-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Free cash flow: -195713 USD Concept: free-cash-flow Period: 2004-09-01 to 2005-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -194447 USD (2004-09-01 to 2005-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001085037-05-001843.txt#2172 Input fundies:CapitalExpenditure: 1266 USD (2004-09-01 to 2005-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001085037-05-001843.txt#2196 The citation records this snapshot. The page link may show a newer release later.
2007 2006-09-01 – 2007-08-31	−USD 3.63 million Exact value Exact value: -3632076 USD 2006-09-01 – 2007-08-31: -3632076 USD Inspect Net Income Open source Share or cite Citation for Net Income · RAPTOR PHARMACEUTICALS CORP. · 2007-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Net Income: -3632076 USD Concept: fundies:NetIncome Period: 2006-09-01 to 2007-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944/explain?concept=fundies%3ANetIncome&period=2007-08-31&surface=latest&period_type=duration&start=2006-09-01&unit=USD&dimensions= Input fundies:NetIncome: -3632076 USD (2006-09-01 to 2007-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001362310-08-008533.txt#7783 The citation records this snapshot. The page link may show a newer release later.	−USD 1.05 million Exact value Exact value: -1045117 USD 2006-09-01 – 2007-08-31: -1045117 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RAPTOR PHARMACEUTICALS CORP. · 2007-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Operating Cash Flow: -1045117 USD Concept: fundies:OperatingCashFlow Period: 2006-09-01 to 2007-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944/explain?concept=fundies%3AOperatingCashFlow&period=2007-08-31&surface=latest&period_type=duration&start=2006-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1045117 USD (2006-09-01 to 2007-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001203944-07-000042.txt#6043 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2008 2007-09-01 – 2008-08-31	−USD 8.05 million Exact value Exact value: -8053963 USD 2007-09-01 – 2008-08-31: -8053963 USD Inspect Net Income Open source Share or cite Citation for Net Income · RAPTOR PHARMACEUTICALS CORP. · 2008-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Net Income: -8053963 USD Concept: fundies:NetIncome Period: 2007-09-01 to 2008-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944/explain?concept=fundies%3ANetIncome&period=2008-08-31&surface=latest&period_type=duration&start=2007-09-01&unit=USD&dimensions= Input fundies:NetIncome: -8053963 USD (2007-09-01 to 2008-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0001362310-08-008533.txt#7783 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2009 2008-09-01 – 2009-08-31	−USD 8.05 million Exact value Exact value: -8053963 USD 2008-09-01 – 2009-08-31: -8053963 USD Inspect Net Income Open source Share or cite Citation for Net Income · RAPTOR PHARMACEUTICALS CORP. · 2009-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Net Income: -8053963 USD Concept: fundies:NetIncome Period: 2008-09-01 to 2009-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944/explain?concept=fundies%3ANetIncome&period=2009-08-31&surface=latest&period_type=duration&start=2008-09-01&unit=USD&dimensions= Input fundies:NetIncome: -8053963 USD (2008-09-01 to 2009-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0000950123-09-054268.txt#12408 The citation records this snapshot. The page link may show a newer release later.	−USD 6.05 million Exact value Exact value: -6045368 USD 2008-09-01 – 2009-08-31: -6045368 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RAPTOR PHARMACEUTICALS CORP. · 2009-08-31 RAPTOR PHARMACEUTICALS CORP. (edgar:1203944) Operating Cash Flow: -6045368 USD Concept: fundies:OperatingCashFlow Period: 2008-09-01 to 2009-08-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203944/explain?concept=fundies%3AOperatingCashFlow&period=2009-08-31&surface=latest&period_type=duration&start=2008-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6045368 USD (2008-09-01 to 2009-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203944/0000950123-09-054268.txt#12660 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

33 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001203944, 1203944, edgar:1203944

Also known as HIGHLAND CLAN CREATIONS CORP, HIGHLAND CLAN CREATIONS CORP.

RAPTOR PHARMACEUTICALS CORP.

Latest quarter

Revenue

Operating cash flow

Trailing twelve months

Net income

Company performance

What changed year over year

Revenue

Net income

Where revenue goes

2009 2008-09-01 – 2009-08-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation